Tagrisso has been approved in the United States for adjuvant treatment of adults patients diagnosed early enough for the tumor to be surgically removed, and who have a mutation of the EGFR gene, AstraZeneca said.
AstraZeneca's Tagrisso gets broader US approval for lung cancer
By AMICHAI STEIN
12/22/2024 12:41 PM
By REUTERS
12/22/2024 11:22 AM
By REUTERS
12/22/2024 07:18 AM
By AMICHAI STEIN
, REUTERS
12/22/2024 05:39 AM
By REUTERS
12/22/2024 03:09 AM
By REUTERS
12/22/2024 02:38 AM
By REUTERS
12/22/2024 01:21 AM
By REUTERS
12/22/2024 01:11 AM
By REUTERS
12/21/2024 11:12 PM
By REUTERS
12/21/2024 09:34 PM
By REUTERS
12/21/2024 08:53 PM